SEC Comment Letter for Heyu Biological Technology Corp (HCIL) (CIK 0001086303) (HCIL) — Jul 27, 2023

Heyu Biological Technology Corp (HCIL) (CIK 0001086303)
Date: July 27, 2023 · CIK: 0001086303 · Accession: 0000000000-23-008073

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-26731

Date

July 27, 2023

Author

Ban Siong Ang

Form

UPLOAD

Company

Heyu Biological Technology Corp (HCIL) (CIK 0001086303)

Letter

United States securities and exchange commission logo July 27, 2023 Ban Siong Ang Chief Executive Officer Heyu Biological Technology Corp Room 1901, Baotuo Building, 617 Sishui Street Huli District, Xiamen City, Fujian Province, China 361009 Re:Heyu Biological Technology Corp Form 10-K for the Fiscal Year Ended December 31, 2022 Filed March 23, 2023 File No. 000-26731 Dear Ban Siong Ang: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
July 27, 2023
Ban Siong Ang
Chief Executive Officer
Heyu Biological Technology Corp
Room 1901, Baotuo Building, 617 Sishui Street
Huli District, Xiamen City,
Fujian Province, China 361009
Re:Heyu Biological Technology Corp
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed March 23, 2023
File No. 000-26731
Dear Ban Siong Ang:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io